Pasireotide: a novel treatment for patients with acromegaly

Pasireotide: a novel treatment for patients with acromegaly

Daniel Cuevas-Ramos,1 Maria Fleseriu2,3 1Department of Endocrinology and Metabolism, Neuroendocrinology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 2Department of Medicine (Endocrinology), 3Department of Neurolog...

Full description

Bibliographic Details
Main Authors: Cuevas-Ramos D, Fleseriu M
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:Drug Design, Development and Therapy
Subjects:
pasireotide
acromegaly
growth hormone
insulin-like growth factor 1
somatostatin receptor ligand
Online Access:https://www.dovepress.com/pasireotide-a-novel-treatment-for-patients-with-acromegaly-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/pasireotide-a-novel-treatment-for-patients-with-acromegaly-peer-reviewed-article-DDDT

Similar Items